Lingraphica co-founder and chief scientist, Dr. Richard Steele, summarizes the recent findings from a primary progressive aphasia study out of Washington, DC. Read on for the details.
Lingraphica co-founder and chief scientist, Dr. Richard Steele, summarizes the recent findings from an aphasia study from Boston University. Read on for the details.
Lingraphica co-founder and chief scientist, Dr. Richard Steele, summarizes the recent findings from an aphasia study in Argentina. Read on for the details.
Lingraphica co-founder and chief scientist, Dr. Richard Steele, summarizes the recent findings from an aphasia study in Norway. Read on for the details.
Lingraphica’s co-founder and chief scientist, Richard Steele, recently co-authored a study, published in Aphasiology, that documents the effectiveness of telerehabilitation when combined with home practice via TalkPath Therapy—a free, online service. Read on for details.
Lingraphica co-founder and chief scientist, Dr. Richard Steele, summarizes the recent findings from an aphasia study in Sweden. Read on for the details.
Backed by more than 30 years of research, Lingraphica created an eBook that shows AAC devices improve functional communication. Read on for the science behind our products.
For many years it was widely believed post-stroke survivors with aphasia would essentially plateau six months into their recovery. In an effort to test this assumption and support the community of adults with chronic aphasia, we studied the effectiveness of our speech-generating devices in the recovery and improvement of speech for adults with aphasia long after onset. Our research proved that adults can improve significantly beyond six months with the help of a speech device.
